EXTENTRAK

Swiss trademark · 714777 · Word mark · In force

Register entry

Registration number
714777
Application number
62558/2017
Status
In force
Type
Word mark
Filed
Oct 9, 2017
Registered
Mar 29, 2018
Published
Mar 29, 2018
Protected until
Oct 9, 2027
Priority
19.09.2017 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Produits pharmaceutiques pour le traitement du cancer, des maladies auto-immunes et des maladies immunologiques; produits pharmaceutiques thérapeutiques pour le traitement du cancer, des maladies auto-immunes et des maladies immunologiques; gamme complète de préparations pharmaceutiques pour le cancer, des maladies auto-immunes et des maladies immunologiques.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 24, 2022

    Agent removed

    Representative
    FMP Fuhrer Marbach & Partner, Konsumstrasse 16A, 3007 Bern (removed)

    Published in Swissreg on 24.01.2022

  2. Jan 24, 2022

    Agent entered

    Representative
    Troller Hitz Troller, Rechtsanwälte, Münstergasse 38, 3011 Bern

    Published in Swissreg on 24.01.2022

  3. Oct 8, 2019

    Agent removed

    Representative
    Novagraaf Switzerland SA, Chemin de l'Echo 3, 1213 Onex (removed)

    Published in Swissreg on 08.10.2019

  4. Oct 8, 2019

    Transferred

    Owner
    Loxo Oncology, Inc., 281 Tresser Boulevard, 9th Floor, Stamford, 06901 Connecticut, USA → Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee, 51373 Leverkusen, Germany
    Representative
    FMP Fuhrer Marbach & Partner, Konsumstrasse 16A, 3007 Bern

    Published in Swissreg on 08.10.2019

  5. Mar 29, 2018

    Registered

    Published in Swissreg on 29.03.2018

Parties

Holder

Bayer Aktiengesellschaft

51373 Leverkusen, DE

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.